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neuralgia
Rekurentni herpes zoster komplikovan segmentnom parezom i postherpetiþnom
neuralgijom
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Abstract
Introduction. Postherpetic neuralgia and segmental pare-
sis represent rare complications of herpes zoster infec-
tion. Recurrent herpes zoster is also rare and occurs
within the first 3 years of the begining of the illness in
only 1.4% of cases but it is generally higher in cases of
chronic lymphatic leukemia (3.5%). Case report. We pre-
sented a patient with lymphatic leukemia who during the
remission had 3 episodes of herpes zoster over a year. All
of them took diffrent parts of the body. One of these epi-
sodes was complicated by postherpetic neuralgia and
segmental paresis. A complete recovery was seen in all the
three episodes. Conclusion.  As immunosuppression is
one of mechanisms of virus reactivation, it is likely asso-
ciated with the described rare complications of herpes
zoster.
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Apstrakt
Uvod. Postherpetiÿna neuralgija i segmentna zoster pareza ne-
ke su od reĀih komplikacija herpes zostera. Rekurentni herpes
zoster je, takoĀe, retkost a viĀa se samo kod 1,4% bolesnika
mada je nešto ÿešýi kod obolelih od hroniÿne limfatiÿne leuke-
mije (3,5%). Prikaz bolesnika. Prikazali smo bolesnika sa
hroniÿnom limfatiÿnom leukemijom koji je za godinu dana, u
vreme remisije osnovne bolesti, imao tri epizode herpes zostera
od kojih je jedna bila komplikovana segmentnom zoster pare-
zom i postherpetiÿnom neuralgijom. Svako od ovih ispoljava-
nja zahvatalo je razliÿite delove tela. Jedno od njih bilo je kom-
plikovano postherpetiÿnom neuralgijom i segmentnom pare-
zom. Kompletan oporavak usledio je posle svake od opisanih
epizoda. Zakljuÿak. Kako je imunosupresija moguýi mehani-
zam reaktivacije virusa, moguýe je da je upravo ona odgovorna
i za pojavu navedenih retkih komplikacija herpes zostera.
Kljuÿne reÿi:
herpes zoster; leukemija, limfocitna, hroniÿna;
komorbiditet; pareza; neuralgija; leÿenje lekovima.
Introduction
Herpes zoster (HZ) is most commonly seen in older
people and in cases of immunodeficiency. Despite higher in-
cidence in immunocompromised patients, the recurrence of
HZ is rare 
1–5.
Postherpetic neuralgia is defined as the existence of
pain at 4 to 6 weeks after vesicular skin eruptions resolve.
Although postherpetic neuralgia is the most common com-
plication of HZ, it occurs in only 5% to 10% of cases 
6.
Typically, it resolves over time but some patients complain
of persistent pain.
A 60 year-old patient with chronic lymphatic leukemia
who in the remission developed 3 episodes of HZ within a
year is presented.
Complications of HZ infection are rare. The most
common is a postherpetic neuralgia and rarely segmental
zoster paresis. Both complications occurred in the presented
case.
Case report
A 60-year-old man with chronic lymphatic leukemia in
remission developed in April 2010 an unpleasant burning pain
along the inner side of the right lower leg, which progressed
over time. The pain was scored 6 out of 10 on the pain scale.
Herpetic rash developed within a week in the area of pain
(Figure 1). Ten days after the initial pain, the patient had diffi-
culty with moving the right foot, which prompted him to make
an appointment. The neurological examination revealed aVolumen 71, Broj 2 VOJNOSANITETSKI PREGLED Strana 215
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moderate to severe weakness of the right ankle plantar flexors
and diminished ankle jerk (3/5 on MRC-scale).
Fig. 1 – Herpetic rash along the inner lower leg.
Electrophysiological examination performed 4 weeks
after the onset of symptoms did not reveal changes in the
nerve motor conduction in the right leg. However, needle
electromyography (EMG) at rest showed denervation poten-
tials (fibrillations and positive sharp waves) in the right gas-
trocnemius muscle and paravertebral muscles innervated by
S1 root. Voluntary activation during EMG examination re-
vealed polyphasic motor unit potentials during activation of
the right foot.
The magnetic resonance imaging (MRI) of the lumbo-
sacral area showed only degenerative changes without other
findings that could explain the neurologic deficits.
Testing serum (ELISA) on HZ virus was positive for
IgM and IgG, which confirmed the presence of HZ infection.
The neurologic findings were ascribed to segmental
herpes paresis.
The patient was referred to physical therapy and pre-
scribed oral gabapentin (900 mg/day) for pain. The patient
was on the same medication for 5 months because of severe
pain, which was afterwards slowly decreased and eventually
discontinued. Motor weakness completely resolved about 6
months after the onset of neurologic symptoms whereas the
pain was sporadic but mild.
About 4 months after the first symptom appearance
(August 2010), the patients noted new-onset burning pain in
the right hand graded 8 out 10 on the pain scale. Five days
later, the herpetic rash developed in the painful area. The pa-
tient did not complain of motor weakness in the right hand.
The overall presentation was consistent with recurrence of HZ
but without other neurological complications. Gabapentin was
again prescribed for pain (1200 mg/day) but only for 6 weeks
at which point the rash and pain disappeared (Figure 2).
Six months later (February 2011), the patient noted dis-
comfort and increased skin sensation over the abdomen fol-
lowed by burning pain (4/10). A few days later herpetic rash
developed in the same area (Figure 3). There were no other
symptoms or sign. Gabapentin was not prescribed this time
considering mild pain. Pain and rash disappeared within 2
months.
Fig. 2 – Herpetic rash in the hand area.
Fig. 3 – Herpetic rash over the abdomen.
Discussion
After primary infection, varicella zoster virus remains
latent in the dorsal root ganglia for several years. The virus
can get reactivated and migrate along the sensory nerves to-
ward the skin innervated by the involved nerve. This results
in HZ rash characterized by vesicular skin eruption accom-
panied by pain and dysesthesia or hyperesthesia corre-
sponding to the affected dermatomes. Pain usually develops
first followed by rash within a week of pain onset. The dis-
ease typically lasts 5–8 weeks 
7. In the presented case, pain
preceded the onset of rash.
The mechanism of virus reactivation is unknown. In
immunocompromised patients, it is likely associated with a
decrease in the immune system, as in cases of lymphoma and
AIDS
 3. The described patient had a chronic lymphatic leu-
kemia that was in remission when the 3 HZ episodes oc-
curred.
The annual incidence of HZ is 3.6/1,000 in general
population or 300,000 new cases a year. Evidently higher in-
cidence of HZ in 6 and 7 decades may be associated with a
decrease in cellular rather than humoral immunity after 60
years of age 
5. The presented case belongs to a typical age
group.
The recurrent HZ is rare and occurs within the first 3
years of the initial insult in only 1.4% of cases. The rate of
recurrent infection is about 10–20% several decades later.
Since the incidence of HZ is generally higher in cases of
chronic lymphatic leukemia (28.6%), the recurrence rate isStrana 216 VOJNOSANITETSKI PREGLED Volumen 71, Broj 2
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also higher (3.5%)
 3. In the presented patient, 3 recurrences
occurred within a year.
There are several approaches to managing post-herpetic
neuralgia. Beginning treatment with antiviral agents as soon
as the rash appears is considered to be the key for preventing
the development of postherpetic neuralgia. Prescribing anti-
viral agents for a week within 3 days of rash (famcyclovir
500 mg tid or acyclovir 1 g tid), decreases pain and the inci-
dence of postherpetic neuralgia 
8–11. Oral corticosteroids for 3
weeks (prednisone 60 mg/day in week 1,30 mg/day in week
2, and 15 mg/day in week 3), along with antiviral agents, can
also reduce the overall severity and duration of pain, and
thereby reduce the incidence of postherpetic neuralgia 11,
12. However, it is not clear whether the mechanism of corti-
costeroid action is local or systemic 
10.
The second most common complication of HZ is seg-
mental motor paresis, which occurs in 0.5% to 5% of pa-
tients 
12, 13. Although the pathophysiology of muscle weak-
ness remains unknown, the overlap between segmental pare-
sis and dermatomal area affected by rash suggests that HZ
virus spreads from the dorsal ganglia toward anterior spinal
roots
 2, 4. This is supported by histological findings typical for
HZ in the anterior roots. Moreover, the absence of fascicula-
tions in the affected muscles on EMG and slowing of motor
conduction velocities suggest axonal lesions rather than the
affection of the anterior horn of the spinal cord. Weakness
typically develops within 2 weeks of rash, however, it may
also precede pain 
7, 13, 14. The possible invasion of the anterior
roots by the HZ virus was first considered by Wohlwill in
1924 
15. In the described case, muscles paresis and the distri-
bution of skin lesions were in the tibial nerve distribution.
In terms of neurophysiology, EMG shows denervation
in the presence of motor weakness. Usual EMG findings in-
clude fibrillation potentials, PDP, and prolonged insertion
activity whereas fasciculations are typically absent. Polypha-
sic motor unit potentials are present upon attempts of volun-
tary activation of weak muscles. This is typically seen in
myotomes that correspond to dermatomes affected by pain
and herpetic eruption. In addition, EMG may reveal a pro-
longed terminal latency, slowing of motor conduction veloc-
ity, occasionally absent motor response, or prolonged motor
latency of the affected nerve or decrease in amplitude 
16. In
the presented case, there was a denervation activity in the
muscles innervated by the tibial nerve in which distribution
was also present the skin lesions.
HZ more often affects proximal than distal portion of
the arms. Although zoster paresis seems more common in the
upper limbs, it was present in this case in the lower limbs but
not in the upper limb that was later affected by the skin le-
sions.
The third episode of HZ affected the abdominal skin but
it was not accompanied by weakness of the abdominal mus-
cles or post-herpetic neuralgia in this region. The outcome of
zoster weakness is generally good. Complete or almost com-
plete recovery within one year occurs in 2/3 of patients 
1, 5,
whereas additional 9% has a partial recovery.
Recovery takes place between 1 and 2 years 
17, 10. Seg-
mental zoster paresis treatment includes analgesics for pain
control, physical therapy, and prevention of contrac-
tures 
10, 18. The presented case was treated in such a way and
the degree and timing of recovery is in agreement with the
literature.
Conclusion
The presented case with chronic lymphatic leukemia is
unique because of 3 recurrent episodes of HZ skin eruptions
in different body regions over the course of several months.
Since only the first episode was accompanied by motor
weakness, it appears that an earlier affliction of the motor
nerve is not a risk factor for developing nerve lesions in the
other area in case of HZ recurrence.
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